Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide on postprandial lipid profile in obese type 2 diabetes
NCT02274740Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Apr 2015
- Primary completion
- Aug 2015
- Modality
- Peptides
01
Overview
A Phase 2 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Apr 2015; status: terminated.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02274740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02274740.